COPENHAGEN - Danish drugmaker Novo Nordisk has been reprimanded by UK regulators for failing to disclose fees and expenses paid to individuals and organisations in Britain amounting to about 7.8 million pounds between 2020 and 2022.
"These payments are for legitimate activities but had been incorrectly categorised in finance systems as a result of human error," the company said in a statement."We accept the PMCPA's decision to rule the relevant breaches of the two Codes of Practice which applied during the timeframe for this case and agreed that this was the appropriate ruling as part of our voluntary admission.
The PMCPA also said on Friday that Swiss pharmaceuticals company Novartis and US rival Pfizer had breached the ABPI's code of practice in more minor ways that brought discredit upon, and reduced confidence in, the pharma industry.A 102-year-old who runs a business shares her longevity tips, including walking every day
Mom's Boyfriend Allegedly Got Frustrated When Her Son, 1, Couldn't Walk by Himself. Now He's Charged with MurderDr. Brian Nadler, the physician acquitted this week of first-degree murder and criminal negligence for his role in the deaths of four patients under his care, is suing the hospital where he worked at the time of his arrest, accusing staff there of making an "abrupt, erroneous and defamatory decision to involve police.